Plasma Pituitary Hormone Responses to the Synthetic Enkephalin Analog (FK 33–824) in Normal Subjects and Patients with Pituitary Diseases*
- 1 February 1981
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 52 (2) , 263-266
- https://doi.org/10.1210/jcem-52-2-263
Abstract
D-Ala, Mephe, Met, enkephalin (Sandoz FK 33– 824) is a stable long acting analog of methionine-enkephalin. FK 33–824 (0.5 or 1.0 mg), elicited plasma GH and PRL responses in normal subjects. In 23 patients with pituitary dwarfism, the response of plasma GH was markedly impaired, while PRL responded to a variable degree. In patients with acromegaly, there was little or no increase in GH and PRL after FK 33–824. Plasma GH increased to a variable degree after FK 33–824 in patients with hyperprolactinemia, with little change in plasma PRL. FK 33–824 decreased plasma cortisol in normal subjectsand patients with pituitary disease. These results show that patients with acromegaly and hyperprolactinemia due to pituitary adenomas and patients with pituitary dwarfism do not respond well to FK 33–824, presumably because of hypothalamic or pituitary derangement.Keywords
This publication has 6 references indexed in Scilit:
- Endocrine Effects of Naloxone-Induced Opiate Receptor Blockade *Journal of Clinical Endocrinology & Metabolism, 1980
- Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation.Proceedings of the National Academy of Sciences, 1980
- HORMONAL AND METABOLIC RESPONSES TO AN ENKEPHALIN ANALOGUE IN NORMAL MANThe Lancet, 1978
- Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormoneLife Sciences, 1977
- STIMULATION IN VIVO OF THE SECRETION OF PROLACTIN AND GROWTH HORMONE BY β-ENDORPHINEndocrinology, 1977
- Enkephalin-stimulated prolactin releaseLife Sciences, 1976